🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
The purpose of this trial is to evaluate the immunogenicity, the safety and...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-05
Trial ID
NCT02106390
Treatments Being Tested
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
The purpose of this study was to assess the safety, effectiveness, and immu...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-06-14
Trial ID
NCT04886154
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
The purpose of this study is to test whether the group B meningitis vaccine...
Status
Completed
Location
University of North Carolina Health Care
Start Date
2019-10-09
Trial ID
NCT04094883
Treatments Being Tested
Primary Objective: To demonstrate the vaccine seroresponse sufficiency of ...
Status
Completed
Location
Investigational Site Number 8400012
Start Date
2019-09-03
Trial ID
NCT04084769
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This study will be conducted in two stages. In the diphtheria, tetanus, per...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06-16
Trial ID
NCT00228917
Treatments Being Tested